# LOTTE Biologics

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/lotte-biologics
Canonical HTML page: https://getbiobrief.com/entity/lotte-biologics

## Recent coverage (1 stories)

### LOTTE Biologics Targets Global CDMO Expansion at DCAT Week 2026
2026-03-09 07:40:26 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

LOTTE Biologics is set to engage with global pharmaceutical leaders at DCAT Week 2026 in New York, aiming to secure strategic partnerships and showcase its expanding CDMO capabilities. The move underscores the company's aggressive push to become a top-tier global contract manufacturer by leveraging its Syracuse and Songdo facilities.
Full story: https://getbiobrief.com/story/lotte-biologics-dcat-week-2026-global-partnerships

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.